Anemia due to malignancy is encountered rarely on Symcat. We will add more content to this page if enough people like you show interest.
Within all the people who go to their doctor with anemia due to malignancy, 42% report having fatigue, 35% report having shortness of breath, and 15% report having difficulty in swallowing. The symptoms that are highly suggestive of anemia due to malignancy are hot flashes and flatulence, although you may still have anemia due to malignancy without those symptoms.
Patients with anemia due to malignancy often receive hematologic tests, complete blood count, glucose measurement, complete physical skin exam performed (ml), electrolytes panel, x-ray computed tomography, examination of breast and pelvis exam .
The most commonly prescribed drugs for patients with anemia due to malignancy include darbepoetin alfa (aranesp), dexamethasone topical product, pegfilgrastim (neulasta), zoledronic acid (reclast), leuprolide (lupron), gemcitabine (gemzar), paclitaxel (taxol), epoetin alfa (procrit), lactulose, pemetrexed (alimta), ferric oxide, saccharated (venofer), filgrastim (neupogen) and rituximab .
|Darbepoetin Alfa (Aranesp)||$1004|
|Dexamethasone Topical Product|
|Zoledronic Acid (Reclast)||$835|
|Epoetin Alfa (Procrit)||$804|
|Ferric Oxide, Saccharated (Venofer)|
Groups of people at highest risk for anemia due to malignancy include age 75+ years age 60-74 years. On the other hand, age 15-29 years and age < 1 years almost never get anemia due to malignancy.